Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo.
Takeda H, Okada M, Kuramoto K, Suzuki S, Sakaki H, Sanomachi T, Seino S, Yoshioka T, Hirano H, Arita K, Kitanaka C.
Takeda H, et al. Among authors: yoshioka t.
Oncotarget. 2017 Jun 29;8(53):90996-91008. doi: 10.18632/oncotarget.18827. eCollection 2017 Oct 31.
Oncotarget. 2017.
PMID: 29207619
Free PMC article.